Clinical trials

The EU came up short in running any pan-European clinical trials to advance the development of COVID-19 vaccines and therapies. It is now trying to fix the problem and be better prepared for future health emergencies

Clinical trials were halted as COVID-19 took hold. But inability to see patients face-to-face has inspired the use of technology to monitor patients remotely, leading to improvements that are here to stay

Health insurers and pharma companies are striking pay-for-results deals under which rebates are offered if a drug does not perform as well in the real world as in clinical trials

Clinical trials are fundamental to the development of new treatments for cancer, but annual accrual to studies worldwide is low, at an estimated at three to five percent.

Poland must break down the silos between academics and industry, to build the trust and infrastructures needed to underpin multilateral collaborations, and enable Polish medical researchers to capitalise on pharma’s thirst for external innovation

The EU-funded BASTION project aims to build relationships between science and industry and promote the translation of cancer research into new treatments. But a number of obstacles must be removed before true collaboration can flourish